Stephen V Liu: Luda Bazhenova Joins DCLung26 to Discuss Immunotherapy Options for NSCLC
Stephen V Liu, Director of Thoracic Oncology, Chief of the Division of Hematology and Oncology, and Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared a post on shared a…
Read the full articleYou might also wanna read
Expert Panel Discussion on Personalized Decision-Making for HER2-Mutated NSCLC
Get the latest updates on HER2-mutated NSCLC.
mdsc.pe·1d ago
Immunotherapy offers new options for some cancer patients
Stephen Graziano, MD (photo by Robert Mescavage) Stephen Graziano, MD (photo by Robert Mescavage) A growing number of medications that influ
Immunotherapy's role in treating cancer; reversing drug addiction; a look at black lung disease: Upstate Medical University's HealthLink on Air for Sunday, April 22, 2018
Oncologist Stephen Graziano, MD, Oncologist Stephen Graziano, MD, discusses immunotherapy as a cancer treatment discusses immunotherapy as a
A Phase Ib Study of Tislelizumab Plus SYS6010 in Immunotherapy-Pretreated Locally Advanced or Metastatic NSCLC
Conditions : NSCLC Interventions : Drug: SYS6010 Sponsors : Sichuan University Not yet recruiting
Dose-reduced thoracic radiotherapy shows promise for older and frail stage III NSCLC patients in randomized trial
In a randomized open-label trial, Wei-Xiang Qi and colleagues investigate the feasibility of dose-reduced thoracic radiotherapy to mitigate
plos.io·1mo ago
The latest information on lung cancer, from screening to diagnosis to treatment options
Interview with Jason Wallen, MD, thoracic surgery chief and medical director of the lung cancer and thoracic oncology program at Upstate
Comments
Sign in to join the conversation.
No comments yet. Be the first.